Benzinga Pro data, GoodRx Holdings (NASDAQ:GDRX) reported Q3 sales of $187.32 million. Earnings fell to a loss of $41.73 million, resulting in a 2849.4% decrease from last quarter. In Q2, GoodRx Holdings brought in $191.80 million in sales but lost $1.42 million in earnings.

Why Is ROIC Significant?

Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company's ROIC. A higher ROIC is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROIC suggests the opposite. In Q3, GoodRx Holdings posted an ROIC of -1.08%.

Keep in mind, while ROIC is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future.

For GoodRx Holdings, a negative ROIC ratio of -1.08% suggests that management may not be effectively allocating their capital. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns; poor capital allocation can be a leech on the performance of a company over time.

Upcoming Earnings Estimate

GoodRx Holdings reported Q3 earnings per share at $0.07/share, which beat analyst predictions of $0.04/share.

This article was generated by Benzinga's automated content engine and reviewed by an editor.